From the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
BioSystems Consult is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €337,981 and a net result of -€2,018. Equity remains stable across the filed financial years (±1.1% per year). Its solvency ranks better than 95% of 9,743 sector peers (NACE 64, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
29-06
financial year 2025 · micro format
2025
31-07
financial year 2024 · micro format
2024
31-12
Financial
Liquidity more than 69 timescurrent ratio 211.78
Current ratio from 3.03 to 211.78; short-term debt falls from €167,519 to €1,586.
10-07
financial year 2023 · micro format
2023
31-12
Financial
Weakest financial yearnet -€18,462
Net result drops to -€18,462, the lowest in the series; recovery starts the following year.
12-07
financial year 2022 · micro format
2022
25-07
financial year 2021 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank